Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
Sharps Technology (NASDAQ: STSS) is urging shareholders to vote in favor of a reverse stock split proposal before the special meeting on October 7, 2024. The company needs to regain compliance with NASDAQ's minimum bid price requirement to maintain its listing. The Board of Directors has recommended a reverse split range of 1-for-8 up to 1-for-22.
CEO Robert M. Hayes emphasized the importance of this vote to preserve investments and enable the company to execute its business plan. Without approval, Sharps Technology expects to be delisted from NASDAQ in the near future, which could adversely affect stock value and trading volume.
Shareholders of record as of August 13, 2024, are eligible to vote. The company encourages all shareholders to vote 'FOR' the proposal to help maintain NASDAQ compliance, ensure easier trading, and provide better access to capital for growth strategies.
Sharps Technology (NASDAQ: STSS) esorta gli azionisti a votare a favore di una proposta di frazionamento azionario inverso prima della riunione straordinaria del 7 ottobre 2024. L'azienda deve riconquistare la conformità con il requisito del prezzo minimo di offerta di NASDAQ per mantenere la propria quotazione. Il Consiglio di Amministrazione ha raccomandato un intervallo di frazionamento inverso di 1 per 8 fino a 1 per 22.
Il CEO Robert M. Hayes ha sottolineato l'importanza di questo voto per preservare gli investimenti e consentire all'azienda di attuare il proprio piano aziendale. Senza approvazione, Sharps Technology prevede di essere esclusa da NASDAQ nel prossimo futuro, il che potrebbe influire negativamente sul valore delle azioni e sul volume degli scambi.
Gli azionisti registrati al 13 agosto 2024 sono idonei a votare. L'azienda incoraggia tutti gli azionisti a votare 'FOR' la proposta per aiutare a mantenere la conformità con NASDAQ, garantire scambi più semplici e fornire un migliore accesso al capitale per le strategie di crescita.
Sharps Technology (NASDAQ: STSS) está instando a los accionistas a votar a favor de una propuesta de división inversa de acciones antes de la reunión especial del 7 de octubre de 2024. La empresa necesita recuperar el cumplimiento con el requisito de precio mínimo de oferta de NASDAQ para mantener su cotización. La Junta Directiva ha recomendado un rango de división inversa de 1 por 8 hasta 1 por 22.
El CEO Robert M. Hayes enfatizó la importancia de esta votación para preservar las inversiones y permitir que la empresa ejecute su plan de negocios. Sin aprobación, Sharps Technology espera ser retirada de NASDAQ en un futuro cercano, lo que podría afectar negativamente el valor de las acciones y el volumen de operaciones.
Los accionistas registrados a partir del 13 de agosto de 2024 son elegibles para votar. La empresa alienta a todos los accionistas a votar 'A FAVOR' de la propuesta para ayudar a mantener el cumplimiento con NASDAQ, asegurar un comercio más fácil y proporcionar un mejor acceso al capital para estrategias de crecimiento.
Sharps Technology (NASDAQ: STSS)는 주주들에게 주식 분할 제안에 찬성 투표를 해줄 것을 촉구하고 있습니다. 이 특별 회의는 2024년 10월 7일에 개최됩니다. 회사는 NASDAQ의 최소 입찰 가격 요건을 충족하여 상장 유지를 위해 다시 일치해야 합니다. 이사회는 1대 8에서 1대 22의 범위 내에서 주식 분할을 권장하고 있습니다.
CEO 로버트 M. 헤이즈는 이 투표가 투자 보호와 회사의 사업 계획 실행을 위해 얼마나 중요한지 강조했습니다. 승인 없이는 Sharps Technology가 가까운 미래에 NASDAQ에서 상장 폐지될 것으로 예상하고 있으며, 이는 주가와 거래량에 악영향을 미칠 수 있습니다.
2024년 8월 13일 현재 주주로 등록된 분들이 투표할 수 있습니다. 회사는 모든 주주들이 NASDAQ 준수를 유지하고, 거래를 더 쉽게 하며, 성장 전략을 위한 자본 접근성을 높이기 위해 제안서에 '찬성' 투표를 하도록 권장하고 있습니다.
Sharps Technology (NASDAQ: STSS) demande aux actionnaires de voter en faveur d'une proposition de regroupement d'actions inversé avant l'assemblée spéciale du 7 octobre 2024. L'entreprise doit retrouver sa conformité avec l'exigence de prix de soumission minimale de NASDAQ pour maintenir sa cotation. Le Conseil d'Administration a recommandé une plage de regroupement inversé de 1 pour 8 à 1 pour 22.
Le PDG Robert M. Hayes a souligné l'importance de ce vote pour préserver les investissements et permettre à l'entreprise d'exécuter son plan d'affaires. Sans approbation, Sharps Technology s'attend à être radiée de NASDAQ dans un avenir proche, ce qui pourrait avoir un impact négatif sur la valeur des actions et le volume des échanges.
Les actionnaires enregistrés au 13 août 2024 sont éligibles pour voter. L'entreprise encourage tous les actionnaires à voter 'POUR' la proposition afin d'aider à maintenir la conformité avec NASDAQ, garantir des échanges plus faciles et fournir un meilleur accès au capital pour des stratégies de croissance.
Sharps Technology (NASDAQ: STSS) fordert die Aktionäre auf, vor der außerordentlichen Hauptversammlung am 7. Oktober 2024 für einen Aktienzusammenlegungsantrag zu stimmen. Das Unternehmen muss die Einhaltung der NASDAQ-Mindestangebotspreisanforderungen wiederherstellen, um seine Listung zu erhalten. Der Vorstand hat einen Rückspaltungsbereich von 1 zu 8 bis 1 zu 22 empfohlen.
CEO Robert M. Hayes betonte die Bedeutung dieser Abstimmung zur Wahrung der Investitionen und zur Erfüllung des Geschäftsplans des Unternehmens. Ohne Genehmigung erwartet Sharps Technology in naher Zukunft von NASDAQ ausgeschlossen zu werden, was sich negativ auf den Aktienwert und das Handelsvolumen auswirken könnte.
Aktionäre, die zum 13. August 2024 im Aktienregister stehen, sind wahlberechtigt. Das Unternehmen ermutigt alle Aktionäre, den Vorschlag mit 'JA' zu unterstützen, um die NASDAQ-Konformität aufrechtzuerhalten, einfachere Handelsmöglichkeiten zu garantieren und den besseren Zugang zu Kapital für Wachstumsstrategien zu ermöglichen.
- None.
- None.
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company’s proposal before the shareholder meeting scheduled to be held on October 7, 2024 at 10:00 a.m. Eastern Time.
“Please take a very important step to preserve your investment and to help ensure that Sharps Technology can continue to execute its business plan,” said Robert M. Hayes, Chief Executive Officer. “We are asking you to vote today ’FOR‘ the reverse split of the Company’s common stock so that we can regain compliance with NASDAQ’s minimum bid price requirement and so that our common stock can remain listed on NASDAQ. This request is consistent with the letter that was included in the Proxy materials previously sent to investors by either email or mail.”
“We acknowledge your support and approval at the July 15, 2024 special shareholder meeting for up to a 1-for-8 reverse stock split. Please note that we have not implemented the reverse stock split that was approved in July,” continued Mr. Hayes. “Based on recent communications and a hearing with NASDAQ, the Board of Directors has recommended and approved a further range for the reverse stock split of 1-for-8 up to 1-for-22 to provide the best opportunity to remain NASDAQ compliant in the long-term.”
“We thank the shareholders that have already voted for the reverse split proposal and would appreciate all of the shareholders who have not yet voted to please vote your approval today.”
THE FOLLOWING WAS CONSIDERED BY THE BOARD PRIOR TO THE APPROVAL RECOMMENDATION:
- Without approval of the reverse stock split proposal at the October 7, 2024 special shareholder meeting, we expect that our stock will be delisted from NASDAQ in the near future. We have been provided an extension to complete this reverse stock split to achieve the minimum
$1.00 NASDAQ stock price requirement.
- If our common stock is delisted from NASDAQ, this could adversely affect the value of the securities that you hold and our trading volume, making it more difficult to buy and sell our securities.
- On the other hand, approval of the reverse stock split should help enable us to maintain our common stock’s volume and ease of trading and encourage a broad range of investors to have the opportunity to invest in our Company. This will encourage analysts and brokers to remain interested in covering and dealing with our securities. The reverse stock split will also allow us to have more access to capital to pursue our management team’s growth strategies.
Following the reverse stock split, we expect to continue to be able to raise capital to grow the Company. Unfortunately, this will likely be more challenging without your vote today “FOR” the reverse stock split proposal.
HOW YOU CAN HELP:
The Definitive Proxy Statement on Schedule 14A regarding the special meeting of our shareholders (the “Special Meeting”), states that it is scheduled to be held on Monday, October 7, 2024. Shareholders as of the Special Meeting’s record date, August 13, 2024, are entitled to vote at the Special Meeting, but are encouraged to vote their proxy beforehand. Sharps’ Board of Directors will unanimously vote in favor of each of the reverse stock split proposal and urges all shareholders to approve the reverse stock split by voting “FOR” the proposal. Please vote your shares “FOR” the proposal today by responding to the proxy materials that were previously sent to all shareholders.
If you require any assistance with voting your shares, please contact our proxy solicitation firm at the telephone number and email below:
ADVANTAGE PROXY, INC.
P.O. Box 10904
Yakima, WA 98909
Toll Free: (877) 870-8565
Collect: (206) 870-8565
Email: ksmith@advantageproxy.com
REVERSE STOCK SPLIT PROCESS:
If the proposal is approved, after the reverse stock split, each shareholder will hold the same percentage interest in the Company as before the reverse stock split; all shareholders will simply hold fewer shares. A reverse stock split decreases the number of our outstanding shares and increases the price per share – and is a mechanism often used by companies to regain and/or maintain compliance with an exchange’s “minimum bid price” listing requirement. For the purpose of regaining compliance with NASDAQ requirements, NASDAQ’s minimum listing price per share is
You can read more about the reverse stock split proposal in the Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission (SEC) on September 4, 2024, and by visiting www.virtualshareholdermeeting.com/STSS2024SM2
A vote “FOR” the proposal will help protect your investment in Sharps Technology and ensure that you can benefit fully from future potential shareholder value creation. We appreciate your continued interest in Sharps Technology, and we are eager to share more with you in future communications.
About Sharps Technology, Inc.
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary and is partnering with Nephron Pharmaceuticals to expand its manufacturing capacity in the U.S. For more information about Sharps Technology, please visit the website at: http://sharpstechnology.com.
Forward-Looking Statements
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
Investor Relations:
Dave Gentry
RedChip Companies, Inc.
1-800-RED-CHIP (733-2447)
Or 407-644-4256
STSS@redchip.com
FAQ
When is Sharps Technology's (STSS) special shareholder meeting?
What is the purpose of Sharps Technology's (STSS) reverse stock split proposal?
What is the recommended reverse stock split range for Sharps Technology (STSS)?
What could happen if Sharps Technology (STSS) shareholders don't approve the reverse stock split?
Who is eligible to vote on Sharps Technology's (STSS) reverse stock split proposal?
